Rectum Cancer: Clinical Trials

2 trials for Rectum Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Rectum Cancer: new trials by email Literature Review of Rectum Cancer trials Research Report on Rectum Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
Indocyanine green, Technetium99, Optonuclear probe - Breast Carcinoma, Head and Neck Cancer
Phase 3CompletedInstitut de Cancérologie de Lorraine7442017-11-292026-09-01
Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial
Educational materials, educational materials, plus patient navigation - Breast Cancer, Colon Cancer
Phase 3CompletedJohns Hopkins Bloomberg School of Public Health2002006-10-012017-04-20

Narrower conditions

Breast Neoplasms (2)  ·  Rectal Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Anus Neoplasms (1)  ·  Carcinoma, Squamous Cell (1)  ·  Colonic Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Breast Diseases (2)  ·  Colorectal Neoplasms (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Rectal Diseases (2)

Interventions

Indocyanine Green (1)  ·  Infracyanine green (1)  ·  Technetium-99 (1)  ·  nanocis (1)

Sponsors

Institut de Cancérologie de Lorraine (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)

Countries

France (1)  ·  United States (1)

Top investigators

Jean G. Ford, MD (1)